skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye
Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye

Maria, Alexandre T.J. ; Delmas, Clement ; Coustal, Cyrille ; Palassin, Pascale ; Roubille, François

European journal of cancer (1990), 2022-12, Vol.177, p.194-196 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer

Alečković, Maša ; Li, Zheqi ; Zhou, Ningxuan ; Qiu, Xintao ; Lulseged, Bethlehem ; Foidart, Pierre ; Huang, Xiao-Yun ; Garza, Kodie ; Shu, Shaokun ; Kesten, Nikolas ; Li, Rong ; Lim, Klothilda ; Garrido-Castro, Ana C ; Guerriero, Jennifer L ; Qi, Jun ; Long, Henry W ; Polyak, Kornelia

Molecular cancer therapeutics, 2023-11, Vol.22 (11), p.1304-1318 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
3
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways

Kraehenbuehl, Lukas ; Weng, Chien-Huan ; Eghbali, Shabnam ; Wolchok, Jedd D ; Merghoub, Taha

Nature reviews. Clinical oncology, 2022-01, Vol.19 (1), p.37-50 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Galluzzi, Lorenzo ; Humeau, Juliette ; Buqué, Aitziber ; Zitvogel, Laurence ; Kroemer, Guido

Nature reviews. Clinical oncology, 2020-12, Vol.17 (12), p.725-741 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Bruni, Daniela ; Angell, Helen K ; Galon, Jérôme

Nature reviews. Cancer, 2020-11, Vol.20 (11), p.662-680 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Doroshow, Deborah Blythe ; Bhalla, Sheena ; Beasley, Mary Beth ; Sholl, Lynette M ; Kerr, Keith M ; Gnjatic, Sacha ; Wistuba, Ignacio I ; Rimm, David L ; Tsao, Ming Sound ; Hirsch, Fred R

Nature reviews. Clinical oncology, 2021-06, Vol.18 (6), p.345-362 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

Tawbi, Hussein A ; Schadendorf, Dirk ; Lipson, Evan J ; Ascierto, Paolo A ; Matamala, Luis ; Castillo Gutiérrez, Erika ; Rutkowski, Piotr ; Gogas, Helen J ; Lao, Christopher D ; De Menezes, Juliana Janoski ; Dalle, Stéphane ; Arance, Ana ; Grob, Jean-Jacques ; Srivastava, Shivani ; Abaskharoun, Mena ; Hamilton, Melissa ; Keidel, Sarah ; Simonsen, Katy L ; Sobiesk, Anne Marie ; Li, Bin ; Hodi, F. Stephen ; Long, Georgina V

The New England journal of medicine, 2022-01, Vol.386 (1), p.24-34 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Immunotherapies for hepatocellular carcinoma
Immunotherapies for hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunotherapies for hepatocellular carcinoma

Llovet, Josep M ; Castet, Florian ; Heikenwalder, Mathias ; Maini, Mala K ; Mazzaferro, Vincenzo ; Pinato, David J ; Pikarsky, Eli ; Zhu, Andrew X ; Finn, Richard S

Nature reviews. Clinical oncology, 2022-03, Vol.19 (3), p.151-172 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Motzer, Robert J. ; Banchereau, Romain ; Hamidi, Habib ; Powles, Thomas ; McDermott, David ; Atkins, Michael B. ; Escudier, Bernard ; Liu, Li-Fen ; Leng, Ning ; Abbas, Alexander R. ; Fan, Jinzhen ; Koeppen, Hartmut ; Lin, Jennifer ; Carroll, Susheela ; Hashimoto, Kenji ; Mariathasan, Sanjeev ; Green, Marjorie ; Tayama, Darren ; Hegde, Priti S. ; Schiff, Christina ; Huseni, Mahrukh A. ; Rini, Brian

Cancer cell, 2020-12, Vol.38 (6), p.803-817.e4 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review

Filleron, Thomas ; Bachelier, Marine ; Mazieres, Julien ; Pérol, Maurice ; Meyer, Nicolas ; Martin, Elodie ; Mathevet, Fanny ; Dauxois, Jean-Yves ; Porcher, Raphael ; Delord, Jean-Pierre

JAMA network open, 2021-12, Vol.4 (12), p.e2139573-e2139573 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (5.928)

Refinar Meus Resultados

Assunto 

  1. Humans  (5.914)
  2. Science & Technology  (5.791)
  3. Life Sciences & Biomedicine  (5.505)
  4. Immune Checkpoint Inhibitors - Therapeutic Use  (3.456)
  5. Immunotherapy  (3.391)
  6. Oncology  (3.047)
  7. Immune Checkpoint Inhibitors  (2.805)
  8. Female  (1.834)
  9. Male  (1.692)
  10. Tumors  (1.607)
  11. Patients  (1.570)
  12. Cancer  (1.562)
  13. Immunology  (1.492)
  14. Middle Aged  (1.287)
  15. Aged  (1.278)
  16. Cancer Therapies  (1.258)
  17. Chemotherapy  (1.216)
  18. Metastasis  (1.131)
  19. Animals  (1.103)
  20. Melanoma  (1.048)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2013  (3)
  2. 2013Até2014  (14)
  3. 2015Até2016  (158)
  4. 2017Até2019  (928)
  5. Após 2019  (5.000)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (6.072)
  2. Japonês  (681)
  3. Chinês  (22)
  4. Francês  (7)
  5. Alemão  (3)
  6. Norueguês  (3)
  7. Português  (3)
  8. Polonês  (1)
  9. Espanhol  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.